Patents by Inventor Preston H. Dorsett

Preston H. Dorsett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080188007
    Abstract: A fluorescent single chain antibody construct is provided comprising a single chain antibody reactive with a target analyte and conjugated with a fluorophore. Also provided is a method for rapid and accurate detection of analytes using the fluorescent single chain antibody construct thereof. Further provided is a diagnostic kit for detecting pathogens using a fluorescent single chain antibody construct comprising a single chain antibody reactive with pathogen-related antigens and conjugated with a fluorophore.
    Type: Application
    Filed: February 6, 2007
    Publication date: August 7, 2008
    Inventors: K. John Morrow, Xiaokang Deng, Robert F. Devlin, Preston H. Dorsett
  • Patent number: 6872396
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Grant
    Filed: October 29, 2003
    Date of Patent: March 29, 2005
    Assignee: Viral Antigens, Inc.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Publication number: 20040096824
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Application
    Filed: October 29, 2003
    Publication date: May 20, 2004
    Applicant: VIRAL ANTIGENTS, INC.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Patent number: 6670117
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: December 30, 2003
    Assignee: Viral Antigens, Inc.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Publication number: 20010055757
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Application
    Filed: May 7, 2001
    Publication date: December 27, 2001
    Applicant: VIRAL ANTIGENS, INC.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Patent number: 4808518
    Abstract: Recovery of antigen from cells containing an intracellular parasite, in particular a virus, by extracting the antigen from the cells with a hypertonic salt solution. CMV antigen extracted in this manner may be supported on particles and used in an agglutination assay for CMV antibody.
    Type: Grant
    Filed: February 11, 1985
    Date of Patent: February 28, 1989
    Assignee: University of Tennessee Research Corporation
    Inventors: Preston H. Dorsett, Robert F. Naegele, Terry S. Ratcliffe
  • Patent number: 4804624
    Abstract: A latex agglutination assay to detect antibodies against pseudorabies virus is provided. The test assays swine serum or plasma for the presence of pseudorabies virus antibody which is indicative of an acute or previous infection or vaccination. The latex reagent is a suspension of latex particles, 0.9 microns in diameter, that have adsorbed thereon antigens from disrupted and solubilized pseudorabies virus. When this material is mixed by rotation with serum containing pseudorabies antibodies, the latex will agglutinate forming visible clumps. In the absence of antibody, the latex suspension will remain smooth and evenly dispersed.
    Type: Grant
    Filed: October 22, 1984
    Date of Patent: February 14, 1989
    Assignee: The University of Tennessee Research Corporation
    Inventor: Preston H. Dorsett
  • Patent number: 4695537
    Abstract: An agglutination immunoassay for antibody wherein antigen for sensitizing a solid particulate support is treated with detergent. The resultant antigen-sensitized support is resistant to self-agglutination.
    Type: Grant
    Filed: April 25, 1985
    Date of Patent: September 22, 1987
    Assignee: The University of Tennessee Research Corp.
    Inventor: Preston H. Dorsett
  • Patent number: 4590156
    Abstract: A solid support is sensitized with soluble rubella virus antigen which is obtained by disruption and solubilization of whole (intact) rubella virus. The sensitized support is useful in an assay for rubella virus antibody.
    Type: Grant
    Filed: May 21, 1982
    Date of Patent: May 20, 1986
    Assignee: The University of Tennessee Research Corporation
    Inventor: Preston H. Dorsett